CRCristin Ryan

Cristin Ryan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cristin Ryan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Adverse Drug Events Due to Potentially Inappropriate Medications—Reply

    by Denis O’mahony, Hilary Jane Hamilton, Paul F. Gallagher, Cristin Ryan, Stephen Byrne

    In reply We note the comments of Drs Sakuma and Morimoto, suggesting caution when interpreting the data in our study published in the Archives on June 13.1 Their first point refers to “retrospectively collected” ADE data in our study. This was not the case. Data were collected prospectively at the point of admission, when World Health Organization–Uppsala Monitoring Committee (WHO-UMC) criteria for ADE detection were applied. Only those cases in which WHO-UMC criteria indicated a “probable” or “definite” ADE on admission to hospital were considered by the local expert panel for determination of whether the ADE was causal or contributory to the index hospitalization or an incidental finding. Furthermore, the local expert panel were not aware of whether these patients were taking Beers or STOPP criteria PIMs during their deliberations on the presence or absence of ADEs.

  • Application of STOPP and START Criteria: Interrater Reliability Among Pharmacists

    by Cristin Ryan, Denis O'MAhony, Stephen Byrne

    BACKGROUND Inappropriate prescribing is a well-documented problem in older people. The new screening tools, STOPP (Screening Tool of Older Peoples’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) have been formulated to identify potentially inappropriate medications (PIMs) and potential errors of omissions (PEOs) in older patients. Consistent, reliable application of STOPP and START is essential for the screening tools to be used effectively by pharmacists. OBJECTIVE To determine the interrater reliability among a group of clinical pharmacists in applying the STOPP and START criteria to elderly patients’ records. METHODS Ten pharmacists (5 hospital pharmacists, 5 community pharmacists) were given 20 patient profiles containing details including the patients’ age and sex, current medications, current diagnoses, relevant medical histories, biochemical data, and estimated glomerular filtration rate. Each pharmacist applied the STOPP and START criteria to each patient record. The PIMs and PEOs identified by each pharmacist were compared with those of 2 academic pharmacists who were highly familiar with the application of STOPP and START. An interrater reliability analysis using the κ statistic (chance corrected measure of agreement) was performed to determine consistency between pharmacists. RESULTS The median κ coefficients for hospital pharmacists and community pharmacists compared with the academic pharmacists for STOPP were 0.89 and 0.88, respectively, while those for START were 0.91 and 0.90, respectively. CONCLUSIONS Interrater reliability of STOPP and START tools between pharmacists working in different sectors is good. Pharmacists working in both hospitals and in the community can use STOPP and START reliably during their everyday practice to identify PIMs and PEOs in older patients.


  • Ordering Off the Menu: Assessing Compliance with a Nonformulary Medication Policy

    by Tara L Pummer, Karen M Shalaby, Sarah C Erush

    Background: Use of nonformulary medications (NFMs) may create added costs and potential safety issues. Institutional policies can support compliance with formulary systems and address these issues. However, periodic review is needed to assess the effectiveness of NFM policies. Objective: To evaluate NFM use at a large university medical center and assess for compliance with the established policy as well as for prescribing errors, procurement procedures, and delivery times. Methods: All new medication orders entered as NFM in the computerized order entry system during a 6-week period were evaluated and followed until administration of the first NFM dose. Orders were categorized as NFMs, formulary medications (FMs), or the patient's own medications. Each order was evaluated to determine the prescriber, service and location of the patient, and any prescribing errors. Additional information, such as the indication, location where the medication was obtained, and the delivery time, was obtained through patient chart review and the pharmacist intervention database. Results: A total of 237 orders were entered as nonformulary; 72 (30%) were FMs and 165(70%) were NFMs. Of the 165 NFM orders, 71 (43%) were orders for the patient's own medication. Of the remaining 94 NFMs, only 39% met the institution's established policy criteria. Overall, 28% of all orders entered as nonformulary had a prescribing error. Of these, 49% were incorrect dosages and 33% were misspelled orders. Seventy percent of NFMs were obtained from the institution's standard locations. The institution's nonformulary turnaround time was achieved with 96% of NFMs. Conclusions: The majority of NFM orders did not meet the institution's established criteria and these orders frequently contained prescribing errors. Routine assessment of NFM use and policy compliance can present opportunities for improvement.